Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,607.98 91.71 0.63%
TOPIX 1,178.17 4.80 0.41%
HANG SENG 22,760.24 64.23 0.28%

Today's Technical View on Unitedhealth Group, Aetna, AstraZeneca, Oncothyreon, and Zogenix



Today's Technical View on Unitedhealth Group, Aetna, AstraZeneca, Oncothyreon,
                                 and Zogenix

PR Newswire

LONDON, March 1, 2013

LONDON, March 1, 2013 /PRNewswire/ --

The Healthcare industry is undergoing a major overhaul after the Supreme Court
last year upheld President Obama's Affordable Care Act (ACA). While critics of
the healthcare reform say that it increase costs for the healthcare industry,
proponents of ACA note that the increase in the number of insured individuals
will ultimately benefit the industry. Meanwhile, healthcare companies such as
UnitedHealth Group Inc. (NYSE: UNH), Aetna Inc. (NYSE: AET), AstraZeneca Plc
(NYSE: AZN), Oncothyreon Inc. (NASDAQ: ONTY) and Zogenix Inc. (NASDAQ: ZGNX)
are adapting to the changing market dynamics. On Thursday, Healthcare sector
managed to post modest gains even as the broad market declined. StockCall
initiated free in-depth technical analysis on UNH, AET, AZN, ONTY and XX which
are currently available upon sign up at http://www.stockcall.com/research

Shares of UnitedHealth Group Inc. edged lower in Thursday's trading session,
extending their losses for the week. The stock closed 0.78% lower at $53.45 on
volume of 5.88 million. It has now fallen more than 1.80% this week.
Year-to-date, UnitedHealth's shares are down nearly 1.50%, underperforming the
S&P 500, which has gained more than 6%. The company's shares currently have
support at around $53. The stock has been facing stiff resistance at around
$55.50. Technical indicators for the stock are currently giving strong bearish
signals. Sign up for the free technical analysis on UNH at
http://www.StockCall.com/UNH030113.pdf  

Shares of diversified healthcare benefits company, Aetna Inc., also slipped in
Thursday' trading session. The stock closed 0.72% lower at $47.19 on above
average volume of 3.42 million. Despite the pullback yesterday, Aetna's shares
have gained more than 1% in the last three trading sessions. Its shares are
currently trading well above their 200-day moving average. However, recent
volume activity suggests that the market sentiment is bearish on the stock.
Its shares are currently trading on a P/E ratio of 9.85. The stock has a
dividend yield of 1.70. Download the free report on AET by registering at
http://www.StockCall.com/AET030113.pdf  

Shares of AstraZeneca Plc ended marginally lower in Thursday's trading
session. The stock closed 0.42% lower at $45.44 on volume of 1.72 million. The
stock has gained 0.58% so far this week. Year-to-date, AstraZeneca Plc shares
have underperformed the broad market, falling nearly 4%. AstraZeneca Plc's
MACD has just crossed the signal line on the upside, which is a bullish
signal. The stock is currently facing resistance at around $46.50. It has
support at around $45. The free report on AZN can be downloaded by signing up
now at http://www.StockCall.com/AZN030113.pdf  

Shares of Oncothyreon Inc. edged higher in Thursday's trading session even as
the broad market slipped. The stock closed 1.47% higher at $2.07 on above
average volume of 932,973, extending its gains in the last three trading
sessions to over 10%. Year-to-date, Oncothyreon's shares have gained more than
7.80%. The stock's MACD is currently trading above the signal line, which is a
bullish signal. The stock broke through $2 resistance level this week, which
is another strong bullish signal. Free report on ONTY can be accessed by
registering at http://www.StockCall.com/ONTY030113.pdf  

Shares of biotechnology company, Zogenix Inc., rallied in Thursday's trading
session, ending the day 10% higher at $1.87 on above average volume of 9.45
million. The stock has now gained more than 46% in the last three trading
sessions. Zogenix's shares have broken through some key technical levels as a
result of the rally this week. Register with StockCall and download the
research on ZGNX for free at http://www.StockCall.com/ZGNX030113.pdf  

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at http://www.stockcall.com

SOURCE StockCall.com

Contact: William T. Knight, Email: info@stockcall.com, Contact Number:
+1-646-396-9857 (9:00 am EST - 01:30 pm EST)
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement